Collegium Pharmaceutical's total assets for Q1 2026 were $1.65B, a decrease of -0.29% from the previous quarter. COLL total liabilities were $1.34B for the fiscal quarter, a -1.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.